**Question:** Absolute contraindication of combined oral contraceptive pill is -

A. Hypersensitivity to estrogen or progestin
B. History of venous thromboembolism (VTE)
C. Recent myocardial infarction or unstable angina
D. Active liver disease or persistent liver enzyme elevations

**Core Concept:**

The combined oral contraceptive pill (COCP) is a widely used form of hormonal contraception, consisting of estrogen and progestin components. Contraindications refer to situations where the use of COCP should be avoided due to serious potential risks. These include both absolute and relative contraindications. Absolute contraindications are conditions that pose a significant risk to the individual's health, while relative contraindications are conditions that may increase the risk but can be managed or monitored before initiating the medication.

**Why the Correct Answer is Right:**

Absolute contraindications are conditions that pose a significant risk to the individual's health when using COCP. In this case, the correct answer is choosing one of the following options:

A. Hypersensitivity (allergic reaction) to estrogen or progestin - Individuals with a history of severe allergic reactions to either estrogen or progestin components of the pill are at high risk of life-threatening allergic reactions and should not use COCP.

C. Recent myocardial infarction or unstable angina - Using COCP in patients with recent myocardial infarction or unstable angina increases the risk of thromboembolic complications due to the progestin component, a situation where the benefits of using COCP outweigh the risks is not present.

**Why Each Wrong Option is Incorrect:**

B. History of venous thromboembolism (VTE) - This is a relative contraindication, not an absolute one. While VTE is a risk factor for COCP users, it can be managed with appropriate anticoagulation therapy, risk assessment, and individualized decision-making.

D. Active liver disease or persistent liver enzyme elevations - This is a relative contraindication, as liver disease increases the risk of adverse effects, such as liver toxicity. However, the patient's clinical condition should be carefully evaluated before initiating COCP, and close monitoring of liver enzymes may be considered. In some cases, the benefits of using COCP may outweigh the risks, but the decision should be made after careful evaluation of the patient's overall health status and risk factors.

**Clinical Pearl:**

In clinical practice, it is essential to assess a patient's medical history, clinical condition, and risk factors before prescribing COCP. While absolute contraindications like allergic reactions to the medication, recent myocardial infarction or unstable angina, and active liver disease or persistent liver enzyme elevations must be carefully evaluated and managed accordingly. In some cases, after thorough evaluation and risk-benefit assessment, COCP may be considered for use, but it is crucial to ensure that the patient does not have these absolute contraindications and is monitored appropriately for potential risks.

**Core Concept Explan